Opioids Drugs Market
Opioids Drugs Market Global Industry Assessment & Forecast
- By Product Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others
- By Application Pain Management, Cough Treatment, Diarrhea
|Forecast Years:||2022 - 2028|
|Historical Years:||2016 - 2021|
|Revenue 2021:||18.96 Billion|
|Revenue 2028:||23.65 Billion|
|Revenue CAGR (2022 - 2028):||2.96|
|Fastest Growing Region (2022 - 2028)||North America|
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
The global Opioids Drugs market was valued at USD 18.96 Billion in 2020 and is projected to reach USD 23.65 Billion by 2028, growing at a CAGR of 2.96% from 2021 to 2028.
|Historical Data (Actual Data)||2016-2020|
|Base Year Data||2020|
|Current Year Date||2021|
|Projected year data||2021-2028|
|Annual Market Size (2028)||23.65 Billion|
|Annual Market Size (2021)|
|CAGR (2021 - 2028)||2.96%|
Overview and Description
Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, suppressing cough.
This report provides an analysis of the Opioids Drugs market for the historic period of 2016–2019 and forecasts for 2021–2028 while 2020 is considered as a base year for estimations. The report includes exhaustive analysis of segments, regions and countries comprising of market size and estimations in terms of revenue for the years 2016–2028. There regional section of the report is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, the report also covers a thorough insights on various tools such as SWOT analysis, PEST analysis, value chain analysis, Porter’s five forces analysis, pricing analysis, and technology roadmap among others. These assessments aid the industry stakeholders to analyze the Opioids Drugs market on the basis of different parameters, such as forward/backward integration, economies of scale, the share of various distribution channels, various factors affecting consumer behavior such as brand loyalty, price, and product availability among others, capital investments, regulatory landscape, production rights and patents, promotional strategies, and other customer preferences. This data is likely to help the industry stakeholders and stimulate the decision-making process.
COVID-19 Impact Analysis
The COVID-19 outbreak has affected various industries worldwide. The Opioids Drugs market is no exception. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop swift spread of COVID-19. These actions led to severe impact on the global economy. Industrialist across the globe were forced to halt their production, leading to supply chain disruptions and impairing of various industries. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.
The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:
o Impact Assessment of COVID-19 Pandemic
o Pre & Post COVID-19 Market Size
o Qualitative analysis on the short term & long-term impact of COVID-19 on the market
o The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.
The report covers exhaustive analysis on the global Opioids Drugs industry, which includes market trends, drivers, restraints, opportunities, segmental analysis, regional trends, and competitive landscape among others. It includes an extensive competitive landscape covering key players in the industry and their comparative study on the basis of different parameters such as company overview, product portfolio, market revenue, business, and marketing strategies. Moreover, the report covers a thorough analysis drivers, restraints, and opportunities considering regional growth factors, technological advancements, and availability of substitute, regulatory norms, and such other growth impacting factors.
Opioids minimize the depth of pain and are usually secure when taken as recommended by the healthcare specialists for smaller duration.
Opioids are generally used to cure pain related with cancer, rheumatic diseases, or sleep disorders, anxiety, and severe pain with respect to diarrhea & coughing. Since opioids efficiently alleviates chronic pain, and addiction in the individuals.
Opioids addictive character has led to drug abuse. Opioid consumption may cause various side effects including drowsiness, constipation, confusion, slowed breathing, nausea, and euphoria.
Global Opioids Drugs Market Report Scope
|Market Size Provided for Years||2016-2028|
|Market Size Provided In Terms Of||Revenue & Volume|
|Segments Covered||Product, Application|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Countries Covered||The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Companies Covered||Allergan, Orexo Pharmaceuticals, Purdue Pharma, Pfizer, AbbVie, Teva pharmaceuticals, Johnson & Johnson, Endo Pharmaceuticals, Sanofi-aventis US LLC, Hospira.|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis|
The report delivers an acute breakdown of the market based on various segments such as Product, Application, and region. The report will cover market estimations and forecast for each segment by region for the years 20156–2028. Several growth factors and opportunities impacting various segments have been incorporated in the report.
On the basis of Product, the market is divided into Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others. oxycodone held the largest share in 2020 and is projected to witness substantial growth during the forecast period.
on Application, the market is divided into Pain Management, Cough Treatment, Diarrhea. pain management
attributed to the highest market share and is expected to grow at a significant
CAGR from 2021 to 2028.
Global Opioids Drugs Market: Product Segment Analysis
Global Opioids Drugs Market: Application Segment Analysis
- Pain Management
- Cough Treatment
Regional Analysis: Preview
Based on the geography, the global Opioids Drugs market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. The regional analysis covers market estimations and forecast for each segment for each region for the years 2016–2028. The regional analysis section also provides qualitative analysis comprising of regional trends such as drivers, restraints, opportunities and regulatory norms. Moreover, the regional sections if further bifurcated into key country level markets for better understanding of the market.
Market Size, 2021 (USD Billion)
Global Opioids Drugs Market: Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
The global Opioids Drugs market report provides an exhaustive competitive landscape to give a comprehensive synopsis of the global market. Major players in the Opioids Drugs market are Allergan, Orexo Pharmaceuticals, Purdue Pharma, Pfizer, AbbVie, Teva pharmaceuticals, Johnson & Johnson, Endo Pharmaceuticals, Sanofi-aventis US LLC, Hospira.. This section of the report comprising of a thorough profiling of companies based on various parameters such as company/business overview, portfolio analysis, business strategies, financial performance, geographical presence, and recent developments among others. Moreover, the report also includes extensive information on key strategies such as new product development/launch, merger & acquisitions, partnerships, collaborations & joint ventures, research & development, and regional expansion.
Frequently Asked Question
The global Opioids Drugs valued at 18.96 Billion in 2020 and is expected to reach 23.65 Billion in 2028 growing at a CAGR of 2.96%.
The prominent players in the market are Allergan, Orexo Pharmaceuticals, Purdue Pharma, Pfizer, AbbVie, Teva pharmaceuticals, Johnson & Johnson, Endo Pharmaceuticals, Sanofi-aventis US LLC, Hospira..
The market is project to grow at a CAGR of 2.96% between 2021 and 2028.
The driving factors of the Opioids Drugs include
- Opioids minimize the depth of pain and are usually secure when taken as recommended by the healthcare specialists for smaller duration.
- Opioids are generally used to cure pain related with cancer, rheumatic diseases, or sleep disorders, anxiety, and severe pain with respect to diarrhea & coughing. Since opioids efficiently alleviates chronic pain, and addiction in the individuals.
North America was the leading regional segment of the Opioids Drugs in 2020.